| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.057 | 0.3 |